An increased relative eosinophil count as a predictive dynamic biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Eiji TakeuchiHirokazu OginoKensuke KondoYoshio OkanoSeiya IchiharaMichihiro KunishigeNaoki KadotaHisanori MachidaNobuo HatakeyamaKeishi NaruseHiroshi NokiharaTsutomu ShinoharaYasuhiko Nishioka

Published in: Thoracic cancer (2023)

ICI-treated NSCLC patients with an increased REC after 4 weeks of treatment had a better DCR and prognosis than the other patients examined.

Keyphrases

end stage renal disease
newly diagnosed
small cell lung cancer
ejection fraction
chronic kidney disease
prognostic factors
peripheral blood
combination therapy